Viewing Study NCT07078214


Ignite Creation Date: 2025-12-18 @ 9:58 AM
Ignite Modification Date: 2025-12-23 @ 6:50 PM
Study NCT ID: NCT07078214
Status: None
Last Update Posted: 2025-07-22 00:00:00
First Post: 2025-06-28 00:00:00
Is Possible Gene Therapy: False
Has Adverse Events: False

Brief Title: Backward Walking Effects on Toe Walking in a Child With ASD: Single-Case Study
Sponsor: None
Organization:

Study Overview

Official Title: The Effect of Backward Walking on Toe Walking Behaviors in a Child With Autism Spectrum Disorder: Single-participant (Subject) Experimental Research
Status: None
Status Verified Date: 2025-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Study Description: Backward Walking Exercise Intervention for Toe Walking in Children with Autism Spectrum Disorder Study Overview This research study investigates whether backward walking exercises can help reduce toe walking behavior in young children with Autism Spectrum Disorder (ASD). Toe walking is a common movement pattern where children walk on their toes instead of using their whole foot, which can affect balance, coordination, and overall development.

Background and Importance Children with Autism Spectrum Disorder often develop unusual walking patterns, including toe walking, which can impact their physical development and daily activities. Traditional approaches to address this behavior have shown limited success, making it important to explore new, evidence-based interventions that can be easily implemented and monitored.

Study Design and Approach

This study uses a single-subject research design, which allows for detailed examination of individual responses to treatment. The research follows a structured A-B-A pattern:

Baseline Phase (1 week): Researchers measure the child's natural walking pattern without any intervention Implementation Phase (9 weeks): The child participates in backward walking exercises on a treadmill Monitoring Phase (1 week): Researchers observe whether improvements continue after stopping the exercises Participants The study focuses on young children (approximately 3-4 years old) who have been diagnosed with Autism Spectrum Disorder and demonstrate persistent toe walking behavior. Participant is carefully selected to ensure they can safely participate in treadmill-based exercises.

What the Study Involves Exercise Program: Children participate in backward walking exercises on a specially adapted treadmill, designed to be safe and appropriate for their developmental level. These sessions occur 5 days per week during the treatment phase.

Measurement Technology: The study uses advanced foot pressure measurement technology (pedobarographic analysis) to precisely track how much of the child's foot touches the ground during walking. This provides objective, quantitative data about walking patterns.

Monitoring and Safety: All activities are supervised by trained researchers and adapted to each child's individual needs and abilities.

Study Duration

The complete study spans 11 weeks:

Week 1: Baseline measurements Weeks 2-10: Backward walking exercise intervention Week 11: Follow-up monitoring Potential Benefits This research may help establish backward walking exercises as an effective, non-invasive intervention for addressing toe walking in children with ASD. The findings could contribute to improved physical therapy approaches and better developmental outcomes for children with autism.

Scientific Significance This study employs rigorous single-subject methodology following established research guidelines (SCRIBE) to ensure reliable and valid results. The use of objective measurement technology provides precise data that can help clinicians and families make informed decisions about treatment approaches.
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: